Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026).

Annals of internal medicine·2026
Same author

Annals On Call - Breast Cancer Screening: Guidance From the American College of Physicians.

Annals of internal medicine·2026
Same author

Associations of obesity phenotypes with incident fall rates: results from the objective physical activity and cardiovascular disease health in older women study.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

The association between 10-year cardiovascular risk and fracture incidence in postmenopausal women: a prospective analysis from the Women's Health Initiative.

Lancet regional health. Americas·2026
Same author

Forearm BMD predicts fracture independently of FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Effects of cocoa extract supplementation on physical performance measures: results from the randomized controlled COcoa Supplement and Multivitamin Outcomes study.

JBMR plus·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Quality indicators for multiple sclerosis.

Eric M Cheng1, Carolyn J Crandall, Christopher T Bever

  • 1Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. eric.cheng@va.gov

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 22, 2010
PubMed
Summary
This summary is machine-generated.

Developing quality indicators for multiple sclerosis (MS) care is crucial for assessing patient healthcare. This study created a comprehensive set of valid indicators to measure and improve the quality of care for individuals with MS.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Related Experiment Videos

Last Updated: Apr 3, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Area of Science:

  • Neurology
  • Healthcare Quality Improvement
  • Health Services Research

Background:

  • Assessing the quality of healthcare for multiple sclerosis (MS) patients necessitates reliable measurement tools.
  • Existing quality metrics may not fully capture the complexities of MS care.
  • A systematic approach is needed to develop evidence-based quality indicators for MS.

Purpose of the Study:

  • To develop a comprehensive set of valid quality indicators for the care of persons with multiple sclerosis (MS).
  • To establish measurable criteria for evaluating the appropriateness and comprehensiveness of MS healthcare.
  • To provide a foundation for interventions aimed at enhancing MS patient care.

Main Methods:

  • A modified RAND/UCLA Appropriateness Method was employed in a two-stage process.
  • Literature reviews, patient interviews, and provider discussions identified key care domains.
  • Multidisciplinary panels of MS stakeholders (including patients) utilized a modified Delphi process to rate domains and indicators.

Main Results:

  • Twenty-five MS symptom and 14 general health domains were identified.
  • Eighty-six potential quality indicators were drafted based on highly ranked domains.
  • Seventy-six of the 86 indicators met predetermined validity thresholds after expert panel review.
  • Highly rated domains included diagnostic work-up, bladder/cognition/depression/fatigue/spasticity management, disease-modifying agent use, and care integration.

Conclusions:

  • A validated, comprehensive set of quality indicators for multiple sclerosis (MS) care has been successfully developed.
  • These indicators provide a robust framework for assessing the quality of care received by MS patients.
  • The developed indicators can guide quality improvement initiatives and interventions for individuals with MS.